瘤血管介导的三级淋巴体结构的形成:解开时空合以优化血管免疫疗法
Lingzhi Lei1, Jun Long2, Changan Chen1
1Department of Pathology and Institute of Oncology, The School of Basic Medical Sciences & Diagnostic Pathology Center, Fujian Medical University, Fuzhou, Fujian, China.
Biochemical pharmacology
|November 29, 2025
概括
瘤血管正常化和三级淋巴体结构 (TLS) 构成一个双生物标志物系统. 该系统有助于评估治疗反应,并确定患者群体的抗血管原和免疫疗法策略.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 血管生物学 血管生物学
背景情况:
- 瘤血管系统支持瘤生长和瘤微环境 (TME) 内的三级淋巴体结构 (TLS) 的形成.
- TLSs位于血管周,这表明血管生成和TLS发展之间存在联系.
- 通过抗血管性疗法实现的瘤血管正常化,旨在恢复血管功能.
研究的目的:
- 审查调节TLS形成和血管正常化的分子机制.
- 分析结合抗血管生成疗法与免疫检查点抑制剂 (ICI) 的好处和挑战.
- 通过精确调节船舶正常化,提出提高TLS功能的策略.
主要方法:
- 关于分子机制的综合文献综述.
- 对血管免疫组合疗法的临床试验数据的分析.
- 整合了关于TLS形成,血管新生和抗血管新生疗法的数据.
主要成果:
- 瘤血管正常化和TLS作为评估治疗反应的双重生物标志物系统.
- 与ICI结合抗血管原剂显示出协同效应,但在治疗窗口的定义和患者选择方面面临挑战.
- 血管内皮细胞影响TLS成熟和淋巴细胞分布.
结论:
- 船舶正常化窗口的精确时空调制可以增强TLS功能.
- 优化联合免疫疗法和抗血管生成策略需要克服目前的治疗局限性.
- 双生物标志物系统为临床治疗决策提供实时评估和预测见解.
相关概念视频
01:27Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
02:17The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
01:10Mechanism of Angiogenesis
6.6K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.6K